Fagonia glutinosa from Libya as a Potential Source of Lead Compounds: GC-MS Characterization of Metabolites with Antimicrobial and Anticancer Activities

Species of Fagonia (family Zygophyllaceae) are drought‑adapted shrubs and herbs distributed throughout North Africa, the Mediterranean Basin, and the Middle East. Traditional healing systems across these regions use Fagonia spp. to treat fever, inflammation, and cancer. Recent studies have uncovered diverse secondary metabolites, including triterpenoid saponins, flavonoids, sterols, and diterpenes, in different species. Libya harbors several Fagonia species, yet the chemical composition and pharmacological activity of the Libyan populations remain poorly characterized. To profile the phytochemicals of Fagonia glutinosa collected from arid Libyan regions using gas chromatography–mass spectrometry (GC-MS) and to evaluate its antimicrobial and cytotoxic activities in vitro. The shade-dried aerial parts were macerated in methanol. The crude extract was analyzed using GC-MS, and the bioactive constituents were identified by comparing the spectra with the NIST library entries. Antibacterial and antifungal activities were assessed against four bacteria and two fungi using agar well diffusion and broth microdilution assays, respectively. Cytotoxicity was measured against MCF‑7 breast cancer and HepG2 liver cancer cell lines using the MTT assay. Data were analyzed using one‑way ANOVA with Tukey’s post hoc test. Twenty-eight constituents, including phytol, hexadecanoic acid methyl ester, squalene, stigmasterol, lupeol, and oleic acid, were identified. The extract displayed broad-spectrum antibacterial activity (MIC 125‑250 µg mL⁻¹) and moderate antifungal activity. MCF‑7 and HepG2 cells exhibited dose-dependent viability reductions with IC₅₀ values of 43.2 µg mL⁻¹ and 57.8 µg mL⁻¹, respectively, and microscopic examination revealed apoptotic morphology. Fagonia glutinosa from Libya possesses a chemically diverse metabolome dominated by terpenoids and fatty acid esters and demonstrates noteworthy antimicrobial and anticancer activities. These findings validate the traditional uses and underscore the potential of this species as a source of lead compounds. Bioassay-guided fractionation and in vivo studies are warranted to isolate the active principles and establish safety profiles.

Authors

Institutions

Publication Details

Journal
Razi Medical Journal
Published
2025-09-23
DOI
https://doi.org/10.69667/rmj.25326
Citations
1
Primary Topic
Ethnobotanical and Medicinal Plants Studies
Type
article
Field-Weighted Citation Impact
1.75
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fagonia glutinosa from Libya as a Potential Source of Lead Compounds: GC-MS Characterization of Metabolites with Antimicrobial and Anticancer Activities

Shamsi Saad Shamsi, Nowar Bhari
1 citations
Razi Medical Journal
Ethnobotanical and Medicinal Plants Studies
1.75
article

Fagonia glutinosa from Libya as a Potential Source of Lead Compounds: GC-MS Characterization of Metabolites with Antimicrobial and Anticancer Activities

Shamsi Saad Shamsi, Nowar Bhari
article en
1 citations

Abstract

Species of Fagonia (family Zygophyllaceae) are drought‑adapted shrubs and herbs distributed throughout North Africa, the Mediterranean Basin, and the Middle East. Traditional healing systems across these regions use Fagonia spp. to treat fever, inflammation, and cancer. Recent studies have uncovered diverse secondary metabolites, including triterpenoid saponins, flavonoids, sterols, and diterpenes, in different species. Libya harbors several Fagonia species, yet the chemical composition and pharmacological activity of the Libyan populations remain poorly characterized. To profile the phytochemicals of Fagonia glutinosa collected from arid Libyan regions using gas chromatography–mass spectrometry (GC-MS) and to evaluate its antimicrobial and cytotoxic activities in vitro. The shade-dried aerial parts were macerated in methanol. The crude extract was analyzed using GC-MS, and the bioactive constituents were identified by comparing the spectra with the NIST library entries. Antibacterial and antifungal activities were assessed against four bacteria and two fungi using agar well diffusion and broth microdilution assays, respectively. Cytotoxicity was measured against MCF‑7 breast cancer and HepG2 liver cancer cell lines using the MTT assay. Data were analyzed using one‑way ANOVA with Tukey’s post hoc test. Twenty-eight constituents, including phytol, hexadecanoic acid methyl ester, squalene, stigmasterol, lupeol, and oleic acid, were identified. The extract displayed broad-spectrum antibacterial activity (MIC 125‑250 µg mL⁻¹) and moderate antifungal activity. MCF‑7 and HepG2 cells exhibited dose-dependent viability reductions with IC₅₀ values of 43.2 µg mL⁻¹ and 57.8 µg mL⁻¹, respectively, and microscopic examination revealed apoptotic morphology. Fagonia glutinosa from Libya possesses a chemically diverse metabolome dominated by terpenoids and fatty acid esters and demonstrates noteworthy antimicrobial and anticancer activities. These findings validate the traditional uses and underscore the potential of this species as a source of lead compounds. Bioassay-guided fractionation and in vivo studies are warranted to isolate the active principles and establish safety profiles.

Razi Medical Journal
Sebha University (LY)
Openalex Percentile: Top 12%
Ethnobotanical and Medicinal Plants Studies
1.75
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.